NYSE:SOLV - New York Stock Exchange, Inc. - US83444M1018 - Common Stock - Currency: USD
This former Dividend King isn't out of the woods yet.
/PRNewswire/ -- The T1D Fund, an impact investment fund with a focus on accelerating life-changing solutions to treat, prevent, and cure type 1 diabetes (T1D),...
A standalone Honeywell aerospace business could be worth up to $120 billion.
/PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its executives will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare...
/PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the third quarter ended September 30, 2024....
3M stock, Dow Jones Industrial Average component, flirted with a breakout on Tuesday morning after reporting better than expected earnings.
Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.
/PRNewswire/ -- Solventum (NYSE: SOLV) will release its third quarter 2024 financial results on Thursday, November 7, 2024 after the U.S. financial markets...
/PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today pledges to use 100% renewable electricity across its worldwide operations by 2030. This...
/PRNewswire/ -- Solventum (NYSE: SOLV) announced today that Dr. Ryan Egeland, MD, has been named chief medical officer. Dr. Egeland is responsible for leading...
/PRNewswire/ -- Solventum (NYSE: SOLV) today announced the launch of the V.A.C.® Peel and Place Dressing, an integrated dressing and drape that can be applied...
September may have a reputation, but investors can find opportunities for growth and value by focusing on solid fundamentals and business models.
The uncertainty around 3M's business is starting to clear, but there are still problems here that must be considered.
The uncertainty around 3M's business is starting to clear, but there are still problems here that must be considered.
/PRNewswire/ -- Solventum (NYSE: SOLV) executives plan to participate in the following investor conferences: 2024 Wells Fargo Healthcare Conference in Everett,...
SOLV stock results show that Solventum beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Solventum (NYSE:SOLV) just reported results for the second quarter of 2024.Solv...
/PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results as a stand-alone company for the second quarter ended June 30, 2024....
These Dow stocks to watch have all been beaten down over the past year or more but are now poised for a rebound.
Earn dividends and participate in earnings growth with these blue-chip stocks that beat Q2 earnings and raised guidance.
3M's fall from grace is at an end, the stock rebound is gaining momentum after better-than-expected results that point to growth and distribution increases.